Breaking News Headlines Today

News from rettsyndrome.org

Ground News rates rettsyndrome.org’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

If you want to know if rettsyndrome.org is credible or reliable, look no further. We rank rettsyndrome.org as Unknown factuality. Find out more about our methodology here.

Information about rettsyndrome.org

Where is rettsyndrome.org located?rettsyndrome.org's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top rettsyndrome.org News

Finance · United States

Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday - Angel Studios (NYSE:ANGX)

100% Center coverage: 1 sources

U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday. Shares of Taysha Gene Therapies Inc (NASDAQ:TSHA) rose sharply during Thursday's session after the FDA granted the company Breakthrough Therapy designation to TSHA-102 for the treatment of Rett syndrome. Needham analyst Gil Blum maintained Taysha Gene Therapies with a Buy and raised the price target from $8 to $10. Taysha Gene Therapies shares jumped 50.4% …See the Story